Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1179 | 9308 | 37.5 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
648 | 3 | ADVANCED GLYCATION END PRODUCTS//HMGB1//METHYLGLYOXAL | 11882 |
1179 | 2 | ADVANCED GLYCATION END PRODUCTS//METHYLGLYOXAL//GLYCATION | 9308 |
282 | 1 | ADVANCED GLYCATION END PRODUCTS//GLYCATION//PENTOSIDINE | 3740 |
2022 | 1 | GLYCATED ALBUMIN//HBA1C//GLYCATED HEMOGLOBIN | 2383 |
5850 | 1 | RAGE//RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS//SRAGE | 1568 |
7166 | 1 | METHYLGLYOXAL//GLYOXALASE I//GLYOXALASE | 1398 |
27848 | 1 | FRUCTOSYL AMINO ACID OXIDASE//FRUCTOSYL AMINE OXIDASE//FRUCTOSAMINE 3 KINASE | 219 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADVANCED GLYCATION END PRODUCTS | authKW | 1550053 | 10% | 53% | 888 |
2 | METHYLGLYOXAL | authKW | 1159935 | 6% | 62% | 570 |
3 | GLYCATION | authKW | 1144077 | 8% | 49% | 714 |
4 | RAGE | authKW | 655351 | 4% | 50% | 403 |
5 | AGES | authKW | 367053 | 2% | 51% | 221 |
6 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | authKW | 363102 | 2% | 59% | 188 |
7 | GLYCATED ALBUMIN | authKW | 329239 | 2% | 66% | 152 |
8 | ADVANCED GLYCATION END PRODUCTS AGES | authKW | 307311 | 2% | 59% | 160 |
9 | PENTOSIDINE | authKW | 283556 | 2% | 60% | 145 |
10 | GLYOXALASE | authKW | 282121 | 1% | 75% | 114 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medical Laboratory Technology | 24570 | 9% | 1% | 811 |
2 | Endocrinology & Metabolism | 19720 | 19% | 0% | 1726 |
3 | Biochemistry & Molecular Biology | 5904 | 24% | 0% | 2254 |
4 | Medicine, Research & Experimental | 1824 | 6% | 0% | 592 |
5 | Urology & Nephrology | 1631 | 5% | 0% | 428 |
6 | Biophysics | 1396 | 6% | 0% | 514 |
7 | Geriatrics & Gerontology | 855 | 2% | 0% | 177 |
8 | Food Science & Technology | 547 | 4% | 0% | 368 |
9 | Chemistry, Applied | 515 | 3% | 0% | 280 |
10 | Medicine, General & Internal | 388 | 5% | 0% | 444 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PATHOPHYSIOL THER EUT DIABET VASC COMPLIC | 104342 | 1% | 41% | 78 |
2 | EXPT DIABET AGING | 86178 | 1% | 56% | 47 |
3 | BIOCHEM MOL VASC BIOL | 85796 | 1% | 55% | 48 |
4 | NEUROIMMUNOL CELL BIOL UNIT | 36877 | 0% | 75% | 15 |
5 | PATHOPHYSIOL SCI | 34726 | 1% | 21% | 51 |
6 | MED CLIN CHEM 1 | 29330 | 0% | 26% | 34 |
7 | METAB VASC MED | 22108 | 0% | 38% | 18 |
8 | FOOD REGULAT BIOL | 21851 | 0% | 67% | 10 |
9 | DIABET PROGRAM ENDOCRINOL | 20980 | 0% | 80% | 8 |
10 | TRANSLAT ADV | 17833 | 0% | 39% | 14 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIABETES CARE | 15006 | 2% | 2% | 231 |
2 | CLINICAL CHEMISTRY | 11046 | 2% | 2% | 202 |
3 | ANNALS OF CLINICAL BIOCHEMISTRY | 10946 | 1% | 3% | 107 |
4 | DIABETOLOGIA | 9006 | 2% | 2% | 153 |
5 | DIABETES | 8861 | 2% | 2% | 183 |
6 | CLINICA CHIMICA ACTA | 8031 | 2% | 2% | 167 |
7 | DIABETES RESEARCH AND CLINICAL PRACTICE | 7859 | 1% | 2% | 114 |
8 | DIABETIC MEDICINE | 5594 | 1% | 2% | 100 |
9 | DIABETES & METABOLISM | 5529 | 1% | 2% | 70 |
10 | CLINICAL BIOCHEMISTRY | 5142 | 1% | 2% | 91 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADVANCED GLYCATION END PRODUCTS | 1550053 | 10% | 53% | 888 | Search ADVANCED+GLYCATION+END+PRODUCTS | Search ADVANCED+GLYCATION+END+PRODUCTS |
2 | METHYLGLYOXAL | 1159935 | 6% | 62% | 570 | Search METHYLGLYOXAL | Search METHYLGLYOXAL |
3 | GLYCATION | 1144077 | 8% | 49% | 714 | Search GLYCATION | Search GLYCATION |
4 | RAGE | 655351 | 4% | 50% | 403 | Search RAGE | Search RAGE |
5 | AGES | 367053 | 2% | 51% | 221 | Search AGES | Search AGES |
6 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | 363102 | 2% | 59% | 188 | Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS | Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS |
7 | GLYCATED ALBUMIN | 329239 | 2% | 66% | 152 | Search GLYCATED+ALBUMIN | Search GLYCATED+ALBUMIN |
8 | ADVANCED GLYCATION END PRODUCTS AGES | 307311 | 2% | 59% | 160 | Search ADVANCED+GLYCATION+END+PRODUCTS+AGES | Search ADVANCED+GLYCATION+END+PRODUCTS+AGES |
9 | PENTOSIDINE | 283556 | 2% | 60% | 145 | Search PENTOSIDINE | Search PENTOSIDINE |
10 | GLYOXALASE | 282121 | 1% | 75% | 114 | Search GLYOXALASE | Search GLYOXALASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | POULSEN, MW , HEDEGAARD, RV , ANDERSEN, JM , DE COURTEN, B , BUGEL, S , NIELSEN, J , SKIBSTED, LH , DRAGSTED, LO , (2013) ADVANCED GLYCATION ENDPRODUCTS IN FOOD AND THEIR EFFECTS ON HEALTH.FOOD AND CHEMICAL TOXICOLOGY. VOL. 60. ISSUE . P. 10 -37 | 218 | 74% | 84 |
2 | VETTER, SW , (2015) GLYCATED SERUM ALBUMIN AND AGE RECEPTORS.ADVANCES IN CLINICAL CHEMISTRY, VOL 72. VOL. 72. ISSUE . P. 205 -275 | 241 | 77% | 2 |
3 | MAESSEN, DEM , STEHOUWER, CDA , SCHALKWIJK, CG , (2015) THE ROLE OF METHYLGLYOXAL AND THE GLYOXALASE SYSTEM IN DIABETES AND OTHER AGE-RELATED DISEASES.CLINICAL SCIENCE. VOL. 128. ISSUE 12. P. 839 -861 | 162 | 76% | 20 |
4 | STINGHEN, AEM , MASSY, ZA , VLASSARA, H , STRIKER, GE , BOULLIER, A , (2016) UREMIC TOXICITY OF ADVANCED GLYCATION END PRODUCTS IN CKD.JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 27. ISSUE 2. P. 354 -370 | 138 | 60% | 13 |
5 | GOLDIN, A , BECKMAN, JA , SCHMIDT, AM , CREAGER, MA , (2006) ADVANCED GLYCATION END PRODUCTS - SPARKING THE DEVELOPMENT OF DIABETIC VASCULAR INJURY.CIRCULATION. VOL. 114. ISSUE 6. P. 597-605 | 104 | 83% | 713 |
6 | STIRBAN, A , GAWLOWSKI, T , RODEN, M , (2014) VASCULAR EFFECTS OF ADVANCED GLYCATION ENDPRODUCTS: CLINICAL EFFECTS AND MOLECULAR MECHANISMS.MOLECULAR METABOLISM. VOL. 3. ISSUE 2. P. 94 -108 | 135 | 76% | 40 |
7 | OTT, C , JACOBS, K , HAUCKE, E , SANTOS, AN , GRUNE, T , SIMM, A , (2014) ROLE OF ADVANCED GLYCATION END PRODUCTS IN CELLULAR SIGNALING.REDOX BIOLOGY. VOL. 2. ISSUE . P. 411 -429 | 128 | 60% | 107 |
8 | REYNAERT, NL , GOPAL, P , RUTTEN, EPA , WOUTERS, EFM , SCHALKWIJK, CG , (2016) ADVANCED GLYCATION END PRODUCTS AND THEIR RECEPTOR IN AGE-RELATED, NON-COMMUNICABLE CHRONIC INFLAMMATORY DISEASES; OVERVIEW OF CLINICAL EVIDENCE AND POTENTIAL CONTRIBUTIONS TO DISEASE.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 81. ISSUE . P. 403 -418 | 171 | 74% | 0 |
9 | MATAFOME, P , SENA, C , SEICA, R , (2013) METHYLGLYOXAL, OBESITY, AND DIABETES.ENDOCRINE. VOL. 43. ISSUE 3. P. 472 -484 | 139 | 79% | 38 |
10 | ALDINI, G , VISTOLI, G , STEFEK, M , CHONDROGIANNI, N , GRUNE, T , SEREIKAITE, J , SADOWSKA-BARTOSZ, I , BARTOSZ, G , (2013) MOLECULAR STRATEGIES TO PREVENT, INHIBIT, AND DEGRADE ADVANCED GLYCOXIDATION AND ADVANCED LIPOXIDATION END PRODUCTS.FREE RADICAL RESEARCH. VOL. 47. ISSUE . P. 93 -137 | 246 | 47% | 18 |
Classes with closest relation at Level 2 |